Among the recent examples: iPSC model of cardio-facio-cutaneous syndrome (CFCS) resulting from germline mutations in BRAF, enabled to show that differentiation of mutated iPSCs towards CMs leads to fibroblast-like cells that influence CM hypertrophy through TGFβ [46]. This evidence concerns the gene BRAF and cardiofaciocutaneous syndrome.